HOUSE, Pa. - Johnson & Johnson (NYSE: NYSE:JNJ) has released new data on nipocalimab, an investigational drug with potential to treat diseases driven by immunoglobulin G (IgG) antibodies. Published in ...

CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEM ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.